IP Library Granted Patent US 11,482,339
Granted Patent B2
US 11,482,339 · App. 16/875,607 · Granted Oct 25, 2022

Systems and methods for estimating hemodynamic forces acting on plaque and monitoring risk

Inventors: Bon-Kwon Koo (Redwood City, CA); Gilwoo Choi (Redwood City, CA); Hyun Jin Kim (Redwood City, CA); Charles A. Taylor (Redwood City, CA)
Assignee: Heartflow, Inc.
G16H50/50A61B5/026A61B5/02007A61B5/0215G16H50/20G16H50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,482,339
App. No.
16/875,607
Granted
Oct 25, 2022
Kind
B2
Abstract

Computer-implemented methods are disclosed for estimating values of hemodynamic forces acting on plaque or lesions. One method includes: receiving one or more patient-specific parameters of at least a portion of a patient's vasculature that is prone to plaque progression, rupture, or erosion; constructing a patient-specific geometric model of at least a portion of a patient's vasculature that is prone to plaque progression, rupture, or erosion, using the received one or more patient-specific parameters; estimating, using one or more processors, the values of hemodynamic forces at one or more points on the patient-specific geometric model, using the patient-specific parameters and geometric model by measuring, deriving, or obtaining one or more of a pressure gradient and a radius gradient; and outputting the estimated values of hemodynamic forces to an electronic storage medium. Systems and computer readable media for executing these methods are also disclosed.

Claims (59)

1. A computer-implemented method for monitoring hemodynamic risk in a patient, the method comprising:

acquiring a patient-specific geometric model of blood flow through at least the portion of the patient's vasculature;

obtaining current physiological and/or blood supply characteristics of the patient;

obtaining one or more patient-specific parameters of at least a portion of the patient's vasculature;

determining current hemodynamic characteristics of the patient based on the patient-specific geometric model, the current physiological and/or blood supply characteristics, and the one or more patient-specific parameters;

obtaining maximum allowable hemodynamic characteristics for the patient;

comparing the current hemodynamic characteristics with the maximum allowable hemodynamic characteristics;

determining, based on the comparison, whether the current hemodynamic characteristics include an abnormal value; and

in response to determining that the current hemodynamic characteristics include an abnormal value, producing a warning indicative of the abnormal value.

2. The computer-implemented method of claim 1 , wherein the current physiological and/or blood supply characteristics of the patient are acquired during exercise by the patient.

3. The computer-implemented method of claim 1 , wherein the current physiological and or blood supply characteristics of the patient are acquired by a mobile device associated with the patient.

4. The computer-implemented method of claim 1 , wherein determining current hemodynamic characteristics of the patient includes:

determining simplified hemodynamics characteristics for at least a portion of the patient-specific geometric model; and

based on the determined simplified hemodynamics characteristics, determining hemodynamic characteristics for a further portion of the patient-specific geometric model at which the simplified hemodynamics characteristics are unknown.

5. The computer-implemented method of claim 4 , wherein determining hemodynamic characteristics for the further portion of the patient-specific geometric model includes employing a machine learning algorithm trained, based on patient-specific parameters of other patients and hemodynamic characteristics associated with one or more portions of patient-specific geometric models of the other patients, to determine hemodynamic characteristics for various portions of a given patient-specific geometric model.

6. The computer-implemented method of claim 1 , wherein obtaining the patient's maximum allowable hemodynamic characteristics includes:

obtaining patient-specific exercise-induced physiological stress characteristics for the patient;

based on the exercise-induced physiological stress characteristics and the one or more patient specific parameters, determining the patient's maximum allowable hemodynamic characteristics.

7. The computer-implemented method of claim 6 , wherein:

determining the patient's maximum allowable hemodynamic characteristics includes inputting the patient-specific exercise-induced physiological stress characteristics and the one or more patient-specific parameters into a trained machine learning algorithm; and

the trained machine learning algorithm is obtained based on one or more patient-specific parameters of a vascular system from each of a plurality of individuals with known values of hemodynamic forces.

8. The computer-implemented method of claim 6 , wherein obtaining the patient-specific exercise-induced physiological stress characteristics includes performing an exercise test on the patient.

9. The computer-implemented method of claim 6 , wherein the patient-specific exercise-induced physiological stress characteristics are determined based on patient medical records.

10. The computer-implemented method of claim 1 , wherein the warning includes a signal provided by a mobile device associated with the patient and/or a physician.

11. The computer implemented method of claim 1 , wherein the one or more patient-specific parameter include one or more measured, derived, or obtained geometric characteristics, plaque characteristics, coronary dynamics characteristics, patient characteristics, or a combination thereof.

12. The computer implemented method of claim 1 , wherein a three-dimensional patient specific model of blood flow includes blood flow through one or more of: a coronary vascular model; a cerebral vascular model; a peripheral vascular model; a hepatic vascular model; a renal vascular model; a visceral vascular model; or any vascular model with vessels supplying blood.

13. The computer implemented method of claim 1 , wherein obtaining the one or more patient-specific parameters includes acquiring a digital representation of the one or more patient-specific parameters using imaging, scanning, or measuring modalities, including, one or more of,

cardiac computerized tomography,

mobile devices and/or smartphones,

intravascular ultrasound (IVUS) imaging,

optical coherence tomography (OCT),

pressure wire measurements,

motorized pull-back measurements,

or a combination thereof.

14. A system for monitoring hemodynamic risk in a patient, the system comprising:

at least one memory storing instructions; and

at least one processor operatively connected to the memory and configured to execute the instructions to perform operations, including:

acquiring a patient-specific geometric model of blood flow through at least the portion of the patient's vasculature;

obtaining current physiological and/or blood supply characteristics of the patient;

obtaining one or more patient-specific parameters of at least a portion of the patient's vasculature;

determining current hemodynamic characteristics of the patient based on the patient-specific geometric model, the current physiological and/or blood supply characteristics, and the one or more patient-specific parameters;

obtaining maximum allowable hemodynamic characteristics for the patient;

comparing the current hemodynamic characteristics with the maximum allowable hemodynamic characteristics;

determining, based on the comparison, whether the current hemodynamic characteristics include an abnormal value; and

in response to determining that the current hemodynamic characteristics include an abnormal value, producing a warning indicative of the abnormal value.

15. The computer-implemented method of claim 14 , wherein the current physiological and/or blood supply characteristics of the patient are acquired during exercise by the patient.

16. The computer-implemented method of claim 14 , wherein the current physiological and or blood supply characteristics of the patient are acquired by a mobile device associated with the patient.

17. The computer-implemented method of claim 14 , wherein the warning includes a signal provided by a mobile device associated with the patient and/or a physician.

18. A non-transitory computer readable medium for use on a computer system containing computer-executable programming instructions for monitoring hemodynamic risk in a patient, the method comprising:

acquiring a patient-specific geometric model of blood flow through at least the portion of the patient's vasculature;

obtaining current physiological and/or blood supply characteristics of the patient;

obtaining one or more patient-specific parameters of at least a portion of the patient's vasculature;

determining current hemodynamic characteristics of the patient based on the patient-specific geometric model, the current physiological and/or blood supply characteristics, and the one or more patient-specific parameters;

obtaining maximum allowable hemodynamic characteristics for the patient;

comparing the current hemodynamic characteristics with the maximum allowable hemodynamic characteristics;

determining, based on the comparison, whether the current hemodynamic characteristics include an abnormal value; and

in response to determining that the current hemodynamic characteristics include an abnormal value, producing a warning indicative of the abnormal value.

19. The non-transitory computer readable medium of claim 18 , wherein the current physiological and/or blood supply characteristics of the patient are acquired by a mobile device associated with the patient during exercise by the patient.

20. The computer-implemented method of claim 19 , wherein the warning includes a signal provided by the mobile device associated with the patient.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Sep 11, 2025
From: HAYFIN SERVICES LLP
To: HEARTFLOW, INC.
Reel/Frame 072876/0775 →
RELEASE OF SECURITY INTEREST Recorded Jun 21, 2024
From: HAYFIN SERVICES LLP
To: HEARTFLOW, INC.
Reel/Frame 067801/0032 →
SECURITY INTEREST Recorded Jun 18, 2024
From: HEARTFLOW, INC.
To: HAYFIN SERVICES LLP
Reel/Frame 067775/0966 →
SECURITY INTEREST Recorded Jan 20, 2021
From: HEARTFLOW, INC.
To: HAYFIN SERVICES LLP
Reel/Frame 055037/0890 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2020
From: KOO, BON-KWON; CHOI, GILWOO; KIM, HYUN JIN; TAYLOR, CHARLES A.
To: HEARTFLOW, INC.
Reel/Frame 052924/0507 →